Latest news
25 items- SECSEC Form 15-12G filed by Conformis Inc.15-12G - Conformis Inc (0001305773) (Filer)
- PRrestor3d Completes Acquisition of ConformisDURHAM, North Carolina and BILLERICA, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis' stockholders at a special meeting held on August 31, 2023. In connection with the completion of the acquisition, shares of Conformis' common stock ceased trading on the NASDAQ prior to the opening of the NASDAQ on September 5, 2023. "We are extremely excited to complete this important transaction and look forward to leveraging our combined portfolio to deliver personalized orthopedic solutions for the whole human body," said J. Kurt Jacobus, CEO o
- INSIDERSEC Form 4: Fischetti Gary P returned 10,470 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- INSIDERSEC Form 4: Johnston Philip W returned 19,273 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- INSIDERSEC Form 4: Augusti Mark A was granted 17,778 shares and returned 190,277 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- INSIDERSEC Form 4: Bienkowski Carrie returned 19,909 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- INSIDERSEC Form 4: Pedulla Denise E returned 18,000 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- INSIDERSEC Form 4: Langdale Bradley returned 18,379 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- INSIDERSEC Form 4: Fallon Kenneth P Iii returned 20,320 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- INSIDERSEC Form 4: Desrochers Christine returned 81,465 shares to the company, closing all direct ownership in the company4 - Conformis Inc (0001305773) (Issuer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
- SECSEC Form S-8 POS filed by Conformis Inc.S-8 POS - Conformis Inc (0001305773) (Filer)
CFMS FAQ
7 questionsWhat does Conformis Inc. do?
Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee; and iTotal Identity, a knee system. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement...Where does CFMS stock trade?
Conformis Inc. (CFMS) is listed on NASDAQ.What sector and industry is CFMS in?
Conformis Inc. operates in the Health Care sector, Industrial Specialties industry.When did Conformis Inc. go public?
Conformis Inc. (CFMS) completed its IPO in 2015.What are analysts saying about CFMS?
Conformis Inc. has had 2 recent analyst actions on file. The most recent action was from Oppenheimer: Outperform with a $200.00 price target on 2021-11-04. Recent price targets range from $200.00 to $250.00.What companies are similar to CFMS?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare CFMS side-by-side with any of them on Quantisnow.How can I track CFMS on Quantisnow?
Quantisnow aggregates Conformis Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CFMS to receive live email and push alerts on every new disclosure.